Cargando…
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
BACKGROUND AND AIM: Angiogenesis is emerging as a pivotal process in chronic inflammatory pathologies, promoting immune infiltration and prompting carcinogenesis. Ulcerative Colitis (UC) and Crohn’s Disease (CD) represent paradigmatic examples of intestinal chronic inflammatory conditions in which t...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878779/ https://www.ncbi.nlm.nih.gov/pubmed/27219328 http://dx.doi.org/10.1371/journal.pone.0156198 |
_version_ | 1782433609570844672 |
---|---|
author | Sarnelli, Giovanni D’Alessandro, Alessandra Iuvone, Teresa Capoccia, Elena Gigli, Stefano Pesce, Marcella Seguella, Luisa Nobile, Nicola Aprea, Giovanni Maione, Francesco de Palma, Giovanni Domenico Cuomo, Rosario Steardo, Luca Esposito, Giuseppe |
author_facet | Sarnelli, Giovanni D’Alessandro, Alessandra Iuvone, Teresa Capoccia, Elena Gigli, Stefano Pesce, Marcella Seguella, Luisa Nobile, Nicola Aprea, Giovanni Maione, Francesco de Palma, Giovanni Domenico Cuomo, Rosario Steardo, Luca Esposito, Giuseppe |
author_sort | Sarnelli, Giovanni |
collection | PubMed |
description | BACKGROUND AND AIM: Angiogenesis is emerging as a pivotal process in chronic inflammatory pathologies, promoting immune infiltration and prompting carcinogenesis. Ulcerative Colitis (UC) and Crohn’s Disease (CD) represent paradigmatic examples of intestinal chronic inflammatory conditions in which the process of neovascularization correlates with the severity and progression of the diseases. Molecules able to target the angiogenesis have thus the potential to synergistically affect the disease course. Beyond its anti-inflammatory effect, palmitoylethanolamide (PEA) is able to reduce angiogenesis in several chronic inflammatory conditions, but no data about its anti-angiogenic activity in colitis have been produced, yet. METHODS: The effects of PEA on inflammation-associated angiogenesis in mice with dextran sulphate sodium (DSS)-induced colitis and in patients with UC were assessed. The release of Vascular Endothelial Growth Factor (VEGF), the hemoglobin tissue content, the expression of CD31 and of phosphatidylinositol 3-kinase/Akt/mammalian-target-of-rapamycin (mTOR) signaling axis were all evaluated in the presence of different concentrations of PEA and concomitant administration of PPAR-α and -γ antagonists. RESULTS: Our results demonstrated that PEA, in a selective peroxisome proliferator activated receptor (PPAR)-α dependent mechanism, inhibits colitis-associated angiogenesis, decreasing VEGF release and new vessels formation. Furthermore, we demonstrated that the mTOR/Akt axis regulates, at least partly, the angiogenic process in IBD and that PEA directly affects this pathway. CONCLUSIONS: Our results suggest that PEA may improve inflammation-driven angiogenesis in colonic mucosa, thus reducing the mucosal damage and potentially affecting disease progression and the shift towards the carcinogenesis. |
format | Online Article Text |
id | pubmed-4878779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48787792016-06-09 Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner Sarnelli, Giovanni D’Alessandro, Alessandra Iuvone, Teresa Capoccia, Elena Gigli, Stefano Pesce, Marcella Seguella, Luisa Nobile, Nicola Aprea, Giovanni Maione, Francesco de Palma, Giovanni Domenico Cuomo, Rosario Steardo, Luca Esposito, Giuseppe PLoS One Research Article BACKGROUND AND AIM: Angiogenesis is emerging as a pivotal process in chronic inflammatory pathologies, promoting immune infiltration and prompting carcinogenesis. Ulcerative Colitis (UC) and Crohn’s Disease (CD) represent paradigmatic examples of intestinal chronic inflammatory conditions in which the process of neovascularization correlates with the severity and progression of the diseases. Molecules able to target the angiogenesis have thus the potential to synergistically affect the disease course. Beyond its anti-inflammatory effect, palmitoylethanolamide (PEA) is able to reduce angiogenesis in several chronic inflammatory conditions, but no data about its anti-angiogenic activity in colitis have been produced, yet. METHODS: The effects of PEA on inflammation-associated angiogenesis in mice with dextran sulphate sodium (DSS)-induced colitis and in patients with UC were assessed. The release of Vascular Endothelial Growth Factor (VEGF), the hemoglobin tissue content, the expression of CD31 and of phosphatidylinositol 3-kinase/Akt/mammalian-target-of-rapamycin (mTOR) signaling axis were all evaluated in the presence of different concentrations of PEA and concomitant administration of PPAR-α and -γ antagonists. RESULTS: Our results demonstrated that PEA, in a selective peroxisome proliferator activated receptor (PPAR)-α dependent mechanism, inhibits colitis-associated angiogenesis, decreasing VEGF release and new vessels formation. Furthermore, we demonstrated that the mTOR/Akt axis regulates, at least partly, the angiogenic process in IBD and that PEA directly affects this pathway. CONCLUSIONS: Our results suggest that PEA may improve inflammation-driven angiogenesis in colonic mucosa, thus reducing the mucosal damage and potentially affecting disease progression and the shift towards the carcinogenesis. Public Library of Science 2016-05-24 /pmc/articles/PMC4878779/ /pubmed/27219328 http://dx.doi.org/10.1371/journal.pone.0156198 Text en © 2016 Sarnelli et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Sarnelli, Giovanni D’Alessandro, Alessandra Iuvone, Teresa Capoccia, Elena Gigli, Stefano Pesce, Marcella Seguella, Luisa Nobile, Nicola Aprea, Giovanni Maione, Francesco de Palma, Giovanni Domenico Cuomo, Rosario Steardo, Luca Esposito, Giuseppe Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner |
title | Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner |
title_full | Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner |
title_fullStr | Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner |
title_full_unstemmed | Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner |
title_short | Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner |
title_sort | palmitoylethanolamide modulates inflammation-associated vascular endothelial growth factor (vegf) signaling via the akt/mtor pathway in a selective peroxisome proliferator-activated receptor alpha (ppar-α)-dependent manner |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878779/ https://www.ncbi.nlm.nih.gov/pubmed/27219328 http://dx.doi.org/10.1371/journal.pone.0156198 |
work_keys_str_mv | AT sarnelligiovanni palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT dalessandroalessandra palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT iuvoneteresa palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT capocciaelena palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT giglistefano palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT pescemarcella palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT seguellaluisa palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT nobilenicola palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT apreagiovanni palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT maionefrancesco palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT depalmagiovannidomenico palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT cuomorosario palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT steardoluca palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner AT espositogiuseppe palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner |